Eisai’s Lecanemab BLA Filing A Key Step For Ailing Biogen

Completed Rolling Submission Beats Lilly’s Donanemab To US FDA

 
• By Mandy Jackson
Retro alarm clock at 5 minutes to 12 o'clock
The clock is ticking in the competition to bring the next anti-amyloid antibody to market • Source: Shutterstock

More from Strategy

More from Business